Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | -122,000 | -165,000 | -73,636 | -68,000 | -71,000 |
| Other Operating Activity | 1,252,000 | 1,926,000 | 1,731,613 | 1,810,000 | 1,308,000 |
| Operating Cash Flow | $1,130,000 | $1,761,000 | $1,657,978 | $1,742,000 | $1,237,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -460,000 | -313,000 | -598,210 | -418,000 | -396,000 |
| Net Acquisitions | -329,000 | -2,000 | -794,166 | -1,000 | 0 |
| Purchase Of Investment | -5,000 | -12,000 | N/A | -8,000 | -9,000 |
| Sale Of Investment | 14,000 | 2,000 | -122 | 1,000 | 30,000 |
| Other Investing Activity | 889,000 | 73,000 | 41,612 | 38,000 | 58,000 |
| Investing Cash Flow | $109,000 | $-252,000 | $-1,350,885 | $-388,000 | $-317,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,522,000 | 693,000 | N/A | 451,000 | 543,000 |
| Debt Repayment | -571,000 | -1,811,000 | N/A | 68,000 | N/A |
| Common Stock Issued | 7,000 | 36,000 | 61,497 | 56,000 | 161,000 |
| Common Stock Repurchased | -1,392,000 | -987,000 | -1,424,646 | -1,113,000 | -642,000 |
| Dividend Paid | -859,000 | -708,000 | -669,562 | -670,000 | -785,000 |
| Other Financing Activity | -80,000 | 8,000 | 3,222,023 | -62,000 | -285,000 |
| Financing Cash Flow | $1,627,000 | $-2,769,000 | $1,189,312 | $-1,270,000 | $-1,008,000 |
| Exchange Rate Effect | 39,000 | -340,000 | 48,904 | -57,000 | 47,000 |
| Beginning Cash Position | -6,541,000 | -6,039,000 | 1,677,000 | -3,282,000 | -3,001,000 |
| End Cash Position | -8,342,000 | -6,541,000 | 3,224,175 | 1,677,000 | -3,282,000 |
| Net Cash Flow | $2,866,000 | $-1,260,000 | $1,496,404 | $84,000 | $-88,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,130,000 | 1,761,000 | 1,657,978 | 1,742,000 | 1,237,000 |
| Capital Expenditure | -466,000 | -315,000 | -612,080 | -424,000 | -401,000 |
| Free Cash Flow | 664,000 | 1,446,000 | 1,045,898 | 1,318,000 | 836,000 |